RVL Pharmaceuticals Revenue

RVL Pharmaceuticals had revenue of $8.26M in the quarter ending June 30, 2023, a decrease of -2.25%. This brings the company's revenue in the last twelve months to $36.92M, up 5.64% year-over-year. In the year 2022, RVL Pharmaceuticals had annual revenue of $49.72M with 184.10% growth.

Revenue (ttm)

36.92M

Revenue Growth

+5.64%

P/S Ratio

n/a

Revenue / Employee

295.35K

Employees

125

Market Cap

111.00

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	49.72M	32.22M	184.10%
Dec 31, 2021	17.50M	-10.26M	-36.96%
Dec 31, 2020	27.76M	-212.27M	-88.43%
Dec 31, 2019	240.03M	-23.67M	-8.98%
Dec 31, 2018	263.70M	17.95M	7.31%
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Marizyme	183.42K
Infinity Pharmaceuticals	2.57M
Seelos Therapeutics	2.01M
American Oriental Bioengineering	121.58M
Gelesis Holdings	12.14M
Athersys	80.00K

Revenue Rankings

RVL Pharmaceuticals News

2 years ago - RVL Pharmaceuticals Earnings Call Transcript: Q2 2023 - Transcripts
3 years ago - RVL Pharmaceuticals Earnings Call Transcript: Q1 2023 - Transcripts
3 years ago - RVL Pharmaceuticals Earnings Call Transcript: Q4 2022 - Transcripts
3 years ago - RVL Pharmaceuticals Earnings Call Transcript: Q3 2022 - Transcripts

More News